A rare viral disease has emerged in an outbreak in Anchorage, and it appears to be expanding, state health officials report.
There are now four new cases in Anchorage of mpox, a viral disease formerly called monkeypox that is spread through close contact and can be fatal.
None of the patients reported traveling outside the state in the month before becoming infected.
It is the highest number of annual mpox cases in Alaska since 2022, when five cases were diagnosed in the state amid a global outbreak. Between 2023 and 2025, there were only two Alaska cases.
Three of the Anchorage cases emerged in October and were reported through a state Department of Health alert intended to raise awareness in the public and among healthcare providers. The fourth case was reported to state officials on Nov. 5, said Dr. Joe McLaughlin, Alaska’s state epidemiologist.
The four Anchorage cases are among men who reported no travel outside of Alaska in the past 30 days, Mclaughlin said. That is a contrast with the previous Alaska cases, all of which were among people who had recent travel experiences. Up to now, travel had been implicated in the spread of mpox in Alaska.
Officials are currently trying to track the source of infection, said McLaughlin and Dr. Randi Rollins, a U.S. Centers for Disease Control epidemiologist working with the Alaska Department of Health.
The lack of reported out-of-state travel “does not necessarily establish that the monkeypox virus is circulating here in Alaska,” Rollins said. “They may have had exposure to somebody who traveled to Alaska, and they may be the end of that transmission line at this point. We don’t know.”
Mpox is characterized by lesions that appear on various parts of the body.
It usually takes three to 17 days after infection for symptoms to emerge, Rollins said, and in the first phase, the symptoms are flu-like: “fever, chills, fatigue, headache, sore muscles, and even swollen lymph nodes.” The lesions develop in the second phase, with bumps that are firm to the touch or sometimes tender, she said.
Some people skip the early symptoms and do not have any signs of infection until the rash phase develops, she said.
The sickness lasts a few weeks, and patients are considered to have recovered when all the lesions are gone. Until that last lesion is completely healed, “the person is still infectious and can transmit monkeypox, and that can typically take two to four weeks,” she said.
McLaughlin said the Alaska patients are isolating and recovering. Two of the reported cases were among men who are partners, but it is unknown whether there are any additional links between any of the patients, he said.
The new outbreak of mpox in Anchorage fits a national pattern. After a lull that followed the 2022-23 global outbreak, cases are on the rise again in the United States. An uptick in infections started in March, the CDC reported.
Spread of the virus happens through close contact, including but not limited to sexual contact.
Alaska health officials are encouraging anyone considered to be at risk of infection to get vaccinated.
The JYNNEOS vaccine, approved by the Food and Drug Administration in 2019, guards against mpox, as well as smallpox, a disease that historically killed much of the world’s population but is now considered to have been eradicated.
The vaccine is effective even for people already infected with the virus, reducing risks even for those who might develop the disease, Rollins said.
The Alaska Beacon is an independent, donor-funded news organization, online at Alaskabeacon.com.